Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 293

Showing 1-25 of 293 citing articles:

Gut microbiome and health: mechanistic insights
Willem M. de Vos, Herbert Tilg, Matthias Van Hul, et al.
Gut (2022) Vol. 71, Iss. 5, pp. 1020-1032
Open Access | Times Cited: 1356
Human gut microbiota in health and disease: Unveiling the relationship
Muhammad Afzaal, Farhan Saeed, Yasir Abbas Shah, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 286
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, et al.
Gut (2021) Vol. 71, Iss. 4, pp. 778-788
Open Access | Times Cited: 245
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
Zheng Zhou, Bao Sun, Dongsheng Yu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 178
Obesity I: Overview and molecular and biochemical mechanisms
Robert H. Lustig, David Collier, Christopher D. Kassotis, et al.
Biochemical Pharmacology (2022) Vol. 199, pp. 115012-115012
Open Access | Times Cited: 122
Gut Microbiota Participates in Polystyrene Microplastics-Induced Hepatic Injuries by Modulating the Gut–Liver Axis
Kai-Kai Zhang, Jian-Zheng Yang, Lijian Chen, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 15125-15145
Closed Access | Times Cited: 78
Bile acids and their receptors: modulators and therapeutic targets in liver inflammation
Anna Bertolini, Romina Fiorotto, Mario Strazzabosco
Seminars in Immunopathology (2022) Vol. 44, Iss. 4, pp. 547-564
Open Access | Times Cited: 74
Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
Tobias Puengel, Hanyang Liu, Adrien Guillot, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2668-2668
Open Access | Times Cited: 72
The gut microbiota promotes distal tissue regeneration via RORγ+ regulatory T cell emissaries
Bola S. Hanna, Gang Wang, Silvia Galván-Peña, et al.
Immunity (2023) Vol. 56, Iss. 4, pp. 829-846.e8
Open Access | Times Cited: 63
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
Kai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 488-498.e14
Closed Access | Times Cited: 49
Microplastic-mediated new mechanism of liver damage: From the perspective of the gut-liver axis
Xiaomei Wang, Kaili Deng, Pei Zhang, et al.
The Science of The Total Environment (2024) Vol. 919, pp. 170962-170962
Closed Access | Times Cited: 33
What defines a healthy gut microbiome?
Matthias Van Hul, Patrice D. Cani, Camille Petitfils, et al.
Gut (2024) Vol. 73, Iss. 11, pp. 1893-1908
Closed Access | Times Cited: 33
Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease
Qichen Long, Fengming Luo, Binghui Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 18
Characteristics and Clinical Significance of Gut Microbiota in Patients With Epstein‐Barr Virus‐Associated Liver Dysfunction
Zhan Yi, Yu Fu, Hanchuan Dai, et al.
Microbiology and Immunology (2025)
Closed Access | Times Cited: 1
Stereoselective effects and its potential mechanism of ofloxacin on the growth and development of Rana nigromaculata: mainly liver lipid metabolism
Wenjun Zhang, Miaomiao Teng, Jin Yan
Frontiers of Environmental Science & Engineering (2025) Vol. 19, Iss. 4
Closed Access | Times Cited: 1
Probiotics and gut microbiome − Prospects and challenges in remediating heavy metal toxicity
K.B. Arun, Aravind Madhavan, Raveendran Sindhu, et al.
Journal of Hazardous Materials (2021) Vol. 420, pp. 126676-126676
Closed Access | Times Cited: 100
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Hui Han, Yi Jiang, Mengyu Wang, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 12, pp. 1689-1706
Closed Access | Times Cited: 87
The Role of the Gut Microbiome in Liver Cirrhosis Treatment
Na Young Lee, Ki Tae Suk
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 199-199
Open Access | Times Cited: 84
Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
Benedikt Simbrunner, Michael Trauner, Thomas Reiberger
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 10, pp. 1243-1262
Open Access | Times Cited: 69
Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 799-815
Closed Access | Times Cited: 52
Intratumor microbiome in cancer progression: current developments, challenges and future trends
Jinyan Liu, Yi Zhang
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 49
The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota
Man Wang, Fei Yu, Yuan Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 4, pp. 1451-1475
Open Access | Times Cited: 46
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response
Yue Shen, Shengdi Wu, Yao Chen, et al.
Gut Microbes (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 43
Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
Amedeo Lonardo, Ashwani K. Singal, Natalia A. Osna, et al.
Metabolism and Target Organ Damage (2022) Vol. 2, pp. 12-12
Open Access | Times Cited: 41
Estrogen deficiency induces bone loss through the gut microbiota
Zhiyuan Guan, Zheng Xuanqi, Junxiong Zhu, et al.
Pharmacological Research (2023) Vol. 196, pp. 106930-106930
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top